Rockwell Medical Inc. (RMTI)
Rockwell Medical Statistics
Share Statistics
Rockwell Medical has 34.17M shares outstanding. The number of shares has increased by 12.34% in one year.
| Shares Outstanding | 34.17M |
| Shares Change (YoY) | 12.34% |
| Shares Change (QoQ) | 5.38% |
| Owned by Institutions (%) | 26.14% |
| Shares Floating | 29.53M |
| Failed to Deliver (FTD) Shares | 163 |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 493.83K, so 1.45% of the outstanding shares have been sold short.
| Short Interest | 493.83K |
| Short % of Shares Out | 1.45% |
| Short % of Float | 1.46% |
| Short Ratio (days to cover) | 1.15 |
Valuation Ratios
The PE ratio is -132 and the forward PE ratio is -8.43. Rockwell Medical's PEG ratio is 1.34.
| PE Ratio | -132 |
| Forward PE | -8.43 |
| PS Ratio | 0.62 |
| Forward PS | 0.5 |
| PB Ratio | 1.94 |
| P/FCF Ratio | 15.08 |
| PEG Ratio | 1.34 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Rockwell Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.34.
| Current Ratio | 2.63 |
| Quick Ratio | 2.22 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 3.76 |
| Debt / FCF | 2.64 |
| Interest Coverage | 0.48 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $415.94K |
| Profits Per Employee | $-1.97K |
| Employee Count | 244 |
| Asset Turnover | 1.71 |
| Inventory Turnover | 14.54 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -19.86% in the last 52 weeks. The beta is 1.62, so Rockwell Medical's price volatility has been higher than the market average.
| Beta | 1.62 |
| 52-Week Price Change | -19.86% |
| 50-Day Moving Average | 1.4 |
| 200-Day Moving Average | 2.38 |
| Relative Strength Index (RSI) | 48.06 |
| Average Volume (20 Days) | 265.19K |
Income Statement
In the last 12 months, Rockwell Medical had revenue of 101.49M and earned -480K in profits. Earnings per share was -0.01.
| Revenue | 101.49M |
| Gross Profit | 17.48M |
| Operating Income | 608K |
| Net Income | -480K |
| EBITDA | 2.95M |
| EBIT | 774K |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 15.66M in cash and 11.1M in debt, giving a net cash position of 4.56M.
| Cash & Cash Equivalents | 15.66M |
| Total Debt | 11.1M |
| Net Cash | 4.56M |
| Retained Earnings | -397.68M |
| Total Assets | 59.21M |
| Working Capital | 22.94M |
Cash Flow
In the last 12 months, operating cash flow was 4.2M and capital expenditures 0, giving a free cash flow of 4.2M.
| Operating Cash Flow | 4.2M |
| Capital Expenditures | 0 |
| Free Cash Flow | 4.2M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 17.23%, with operating and profit margins of 0.6% and -0.47%.
| Gross Margin | 17.23% |
| Operating Margin | 0.6% |
| Pretax Margin | -0.47% |
| Profit Margin | -0.47% |
| EBITDA Margin | 2.91% |
| EBIT Margin | 0.6% |
| FCF Margin | 4.14% |
Dividends & Yields
RMTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for RMTI is $4, which is 241.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $4 |
| Price Target Difference | 241.9% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on May 13, 2022. It was a backward split with a ratio of 1:11.
| Last Split Date | May 13, 2022 |
| Split Type | backward |
| Split Ratio | 1:11 |
Scores
| Altman Z-Score | -6.3 |
| Piotroski F-Score | 5 |